Microparticles and infectious diseases

Medecine et Maladies Infectieuses

Volumn 42, Issue 8, 2012, Pages 335-343

  Delabranche, X ^a,b,c   Berger, A ^a,b   Boisrame Helms J ^a,b   Meziani, F ^a,b  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Coagulopathy; Inflammation; Microorganisms; Microparticles; Sepsis

Indexed keywords

ANTICOAGULANT AGENT; CELL ANTIGEN; DROTRECOGIN; PHOSPHATIDYLSERINE; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA;

BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; BLOOD VESSEL TONE; BRAIN MALARIA; CELL COMPARTMENTALIZATION; CHAGAS DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FULMINATING PURPURA; HEART DISEASE; HEMOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; INTRACELLULAR MEMBRANE; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; MENINGOCOCCEMIA; MOLECULAR PATHOLOGY; NEISSERIA MENINGITIDIS; NONHUMAN; PHAGOCYTOSIS; REVIEW; SEPTIC SHOCK; TARGET CELL; UPREGULATION;

CELL-DERIVED MICROPARTICLES; HUMANS; INFECTION;

EID: 84864586916     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.05.011     Document Type: Review

References (50)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
2. Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 2010, 64:163-184.
3. Hugel B., Martinez M.C., Kunzelmann C., Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005, 20:22-27.
4. Kueng H.J., Schmetterer K.G., Pickl W.F. Lipid rafts, pseudotyping, and virus-like particles: relevance of a novel, configurable, and modular antigen-presenting platform. Int Arch Allergy Immunol 2011, 154:89-110.
5. Zwaal R.F., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132.
6. Morel O., Jesel L., Freyssinet J.M., Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011, 31:15-26.
7. Henseleit U., Plasa G., Haest C. Effects of divalent cations on lipid flip-flop in the human erythrocyte membrane. Biochim Biophys Acta 1990, 2:127-135.
8. Cauwenberghs S., Feijge M.A., Harper A.G., Sage S.O., Curvers J., Heemskerk J.W. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006, 580:5313-5320.
9. Michel V., Bakovic M. Lipid rafts in health and disease. Biol Cell 2007, 99:129-140.
10. Meziani F., Delabranche X., Asfar P., Toti F. Bench-to-bedside review: circulating microparticles--a new player in sepsis?. Crit Care 2010, 14:236.
11. Frey B., Gaipl U.S. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 2011, 33:497-516.
12. Yoshida H., Kawane K., Koike M., Mori Y., Uchiyama Y., Nagata S. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 2005, 437:754-758.
13. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002, 417:182-187.
14. Ishimoto Y., Ohashi K., Mizuno K., Nakano T. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem 2000, 127:411-417.
15. Lucas M., Stuart L.M., Zhang A., Hodivala-Dilke K., Febbraio M., Silverstein R., et al. Requirements for apoptotic cell contact in regulation of macrophage responses. J Immunol 2006, 177:4047-4054.
16. Kim S., Bae D.J., Hong M., Park S.Y., Kim I.S. The conserved histidine in epidermal growth factor-like domains of stabilin-2 modulates pH-dependent recognition of phosphatidylserine in apoptotic cells. Int J Biochem Cell Biol 2010, 42:1154-1163.
17. Dasgupta S.K., Abdel-Monem H., Niravath P., Le A., Bellera R.V., Langlois K., et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009, 113:1332-1339.
18. Jy W., Horstman L.L., Jimenez J.J., Ahn Y.S., Biro E., Nieuwland R., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
19. Lane D.A., Philippou H., Huntington J.A. Directing thrombin. Blood 2005, 106:2605-2612.
20. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwege V., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994, 153:3245-3255.
21. Egorina E.M., Sovershaev M.A., Olsen J.O., Osterud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 2008, 111:1208-1216.
22. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95:930-935.
23. Yun T.H., Morrissey J.H. Polyphosphate and omptins: novel bacterial procoagulant agents. J Cell Mol Med 2009, 13:4146-4153.
24. Satta N., Freyssinet J.M., Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol 1997, 96:534-542.
25. Perez-Casal M., Downey C., Fukudome K., Marx G., Toh C.H. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood 2005, 105:1515-1522.
26. Perez-Casal M., Thompson V., Downey C., Welters I., Wyncoll D., Thachil J., et al. The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis. Crit Care 2011, 15.
27. Soriano A.O., Jy W., Chirinos J.A., Valdivia M.A., Velasquez H.S., Jimenez J.J., et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005, 33:2540-2546.
28. Janiszewski M. Do Carmo AO, Pedro MA, Silva E, Knobel E, Laurindo FR. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit Care Med 2004, 32:818-825.
29. Boulanger C.M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001, 104:2649-2652.
30. Mortaza S., Martinez M.C., Baron-Menguy C., Burban M., de la Bourdonnaye M., Fizanne L., et al. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med 2009, 37:2045-2050.
31. Ovstebo R., Dalsbotten Aass H.C., Haug K.B., Siebke Troseid A.M., Gopinathan U., Kierulf P., et al. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun 2011, 10.1177/1753425911428230.
32. Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011, 377:849-862.
33. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Kagan E., Hensley L.E. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003, 188:1618-1629.
34. Hensley L.E., Stevens E.L., Yan S.B., Geisbert J.B., Macias W.L., Larsen T., et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007, 196(Suppl 2):S390-S399.
35. Cestari I., Ansa-Addo E., Deolindo P., Inal J.M., Ramirez M.I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J Immunol 2012, 188:1942-1952.
36. Francischetti I.M., Seydel K.B., Monteiro R.Q. Blood coagulation, inflammation, and malaria. Microcirculation 2008, 15:81-107.
37. Moxon C.A., Heyderman R.S., Wassmer S.C. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol 2009, 166:99-108.
38. de Mast Q., de Groot P.G., van Heerde W.L., Roestenberg M., van Velzen J.F., Verbruggen B., et al. Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy. Br J Haematol 2010, 151:495-503.
39. Larkin D., de Laat B., Jenkins P.V., Bunn J., Craig A.G., Terraube V., et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 2009, 5:e1000349.
40. Lowenberg E.C., Charunwatthana P., Cohen S., van den Born B.J., Meijers J.C., Yunus E.B., et al. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb Haemost 2010, 103:181-187.
41. Combes V., Coltel N., Alibert M., van Eck M., Raymond C., Juhan-Vague I., et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 2005, 166:295-302.
42. Faille D., Combes V., Mitchell A.J., Fontaine A., Juhan-Vague I., Alessi M.C., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 2009, 23:3449-3458.
43. Nantakomol D., Dondorp A.M., Krudsood S., Udomsangpetch R., Pattanapanyasat K., Combes V., et al. Circulating red cell-derived microparticles in human malaria. J Infect Dis 2011, 203:700-706.
44. Couper K.N., Barnes T., Hafalla J.C., Combes V., Ryffel B., Secher T., et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog 2010, 6:e1000744.
45. Srivastava K., Cockburn I.A., Swaim A., Thompson L.E., Tripathi A., Fletcher C.A., et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 2008, 4:179-187.
46. Cantin R., Diou J., Belanger D., Tremblay A.M., Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods 2008, 338:21-30.
47. Callahan M.K., Popernack P.M., Tsutsui S., Truong L., Schlegel R.A., Henderson A.J. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J Immunol 2003, 170:4840-4845.
48. Munoz L.E., Franz S., Pausch F., Furnrohr B., Sheriff A., Vogt B., et al. The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J Leukoc Biol 2007, 81:6-14.
49. Raymond A.D., Campbell-Sims T.C., Khan M., Lang M., Huang M.B., Bond V.C., et al. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses 2011, 27:167-178.
50. Mayne E., Funderburg N.T., Sieg S.F., Asaad R., Kalinowska M., Rodriguez B., et al. Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression. J Acquir Immune Defic Syndr 2012, 59:340-346.